GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (LTS:0I7E) » Definitions » Cyclically Adjusted PS Ratio

DaVita (LTS:0I7E) Cyclically Adjusted PS Ratio : 1.40 (As of May. 25, 2024)


View and export this data going back to 2018. Start your Free Trial

What is DaVita Cyclically Adjusted PS Ratio?

As of today (2024-05-25), DaVita's current share price is $137.615. DaVita's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $98.24. DaVita's Cyclically Adjusted PS Ratio for today is 1.40.

The historical rank and industry rank for DaVita's Cyclically Adjusted PS Ratio or its related term are showing as below:

LTS:0I7E' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.78   Med: 1.47   Max: 2.33
Current: 1.41

During the past years, DaVita's highest Cyclically Adjusted PS Ratio was 2.33. The lowest was 0.78. And the median was 1.47.

LTS:0I7E's Cyclically Adjusted PS Ratio is ranked worse than
53.53% of 340 companies
in the Healthcare Providers & Services industry
Industry Median: 1.195 vs LTS:0I7E: 1.41

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

DaVita's adjusted revenue per share data for the three months ended in Mar. 2024 was $33.911. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $98.24 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


DaVita Cyclically Adjusted PS Ratio Historical Data

The historical data trend for DaVita's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Cyclically Adjusted PS Ratio Chart

DaVita Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.32 1.84 1.52 0.87 1.10

DaVita Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 1.10 1.01 1.10 1.40

Competitive Comparison of DaVita's Cyclically Adjusted PS Ratio

For the Medical Care Facilities subindustry, DaVita's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where DaVita's Cyclically Adjusted PS Ratio falls into.



DaVita Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

DaVita's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=137.615/98.24
=1.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaVita's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, DaVita's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=33.911/131.7762*131.7762
=33.911

Current CPI (Mar. 2024) = 131.7762.

DaVita Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 14.639 100.560 19.183
201409 14.969 100.428 19.642
201412 15.292 99.070 20.340
201503 15.408 99.621 20.381
201506 15.784 100.684 20.658
201509 16.270 100.392 21.356
201512 -1.250 99.792 -1.651
201603 17.223 100.470 22.590
201606 17.869 101.688 23.156
201609 18.026 101.861 23.320
201612 13.721 101.863 17.750
201703 13.474 102.862 17.261
201706 13.915 103.349 17.742
201709 14.446 104.136 18.280
201712 15.046 104.011 19.062
201803 15.670 105.290 19.612
201806 16.582 106.317 20.553
201809 17.023 106.507 21.062
201812 16.952 105.998 21.075
201903 16.447 107.251 20.208
201906 17.043 108.070 20.782
201909 19.195 108.329 23.350
201912 22.239 108.420 27.030
202003 22.390 108.902 27.093
202006 23.213 108.767 28.124
202009 23.590 109.815 28.308
202012 25.108 109.897 30.107
202103 24.769 111.754 29.207
202106 26.175 114.631 30.090
202109 26.751 115.734 30.459
202112 28.093 117.630 31.472
202203 28.035 121.301 30.456
202206 29.935 125.017 31.554
202209 31.617 125.227 33.271
202212 31.748 125.222 33.410
202303 31.062 127.348 32.142
202306 32.118 128.729 32.878
202309 33.191 129.860 33.681
202312 33.907 129.419 34.524
202403 33.911 131.776 33.911

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


DaVita  (LTS:0I7E) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


DaVita Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of DaVita's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


DaVita (LTS:0I7E) Business Description

Traded in Other Exchanges
Address
2000 16th Street, Denver, CO, USA, 80202
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

DaVita (LTS:0I7E) Headlines

No Headlines